title: 3β-hydroxysteroid dehydrogenase type II deficiency on newborn screening test.
abstract: 3β-hydroxysteroid dehydrogenase II (3β-HSD) deficiency represents a rare CAH variant. Newborns affected with its classic form have salt wasting in early infancy and genital ambiguity in both sexes. High levels of 17-hydroxypregnenolone (Δ517OHP) are characteristic, but extra-adrenal conversion to 17-hydroxyprogesterone (17OHP) may lead to positive results on newborn screening tests. Filter paper 17OHP on newborn screening test was performed by immunofluorometric assay, and serum determinations of 17OHP and Δ517OHP, by radioimmunoassay. A 46,XY infant with genital ambiguity and adrenal crisis at three months of age presented a positive result on newborn screening for CAH. Serum determinations of 17OHP and Δ517OHP were elevated, and a high Δ517OHP/cortisol relation was compatible with the diagnosis of 3β-HSD deficiency. Molecular analysis of the HSD3B2 gene from the affected case revealed the presence of the homozygous p.P222Q mutation, whereas his parents were heterozygous for it. We present the first report of 3β-HSD type II deficiency genotype-proven detected at the Newborn Screening Program in Brazil. The case described herein corroborates the strong genotype-phenotype correlation associated with the HSD3B2 p.P222Q mutation, which leads to a classic salt-wasting 3β-HSD deficiency. Further evaluation of 17OHP assays used in newborn screening tests would aid in determining their reproducibility, as well as the potential significance of moderately elevated 17OHP levels as an early indicator to the diagnosis of other forms of classic CAH, beyond 21-hydroxylase deficiency.
authors.affiliation: Molecular Pharmacology Laboratory, Faculty of Health Sciences, University of Brasilia, Brasilia, DF, Brazil.
authors.forename: Vitor Guilherme Brito de
authors.initials: VG
authors.lastname: Araújo
authors.affiliation: Molecular Pharmacology Laboratory, Faculty of Health Sciences, University of Brasilia, Brasilia, DF, Brazil.
authors.forename: Renata Santarem de
authors.initials: RS
authors.lastname: Oliveira
authors.affiliation: Genetics Unit, Hospital de Apoio de Brasilia, Brasilia, DF, Brazil.
authors.forename: Kallianna Paula Duarte
authors.initials: KP
authors.lastname: Gameleira
authors.affiliation: Pediatric Endocrinology Unit, University Hospital of Brasilia, UnB, Brasilia, DF, Brazil.
authors.forename: Cátia Barbosa
authors.initials: CB
authors.lastname: Cruz
authors.affiliation: Molecular Pharmacology Laboratory, Faculty of Health Sciences, University of Brasilia, Brasilia, DF, Brazil.
authors.forename: Adriana
authors.initials: A
authors.lastname: Lofrano-Porto
mesh_terms: D006907:17-alpha-Hydroxypregnenolone / Q000097:blood*; D000312:Adrenal Hyperplasia, Congenital / Q000175:diagnosis*; D012734:Disorders of Sex Development; D006720:Homozygote; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D009154:Mutation; D015997:Neonatal Screening / Q000379:methods*; D011375:Progesterone Reductase / Q000172:deficiency* / Q000235:genetics; D035583:Rare Diseases
chemical_list: D006907:17-alpha-Hydroxypregnenolone; C533068:3 beta-hydroxysteroid dehydrogenase type II; D011375:Progesterone Reductase